Company intelligence / Profile preview

OBS Medical

Cirencester, England, United Kingdomobsmedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

Visensia – The Safety Index uses AI to provide real-time patient risk stratification and alerts. It has regulatory clearance in key global markets including FDA clearance in the US and CE Marking in Europe. No direct clinical trial results are published; the product’s value proposition centers on improved safety through early detection of patient deterioration.

Therapeutic areas: Other
Modalities: DeviceSoftware (Clinical decision support system)
Industry: Digital Health Medical Devices

Partnerships

University of Oxford (spin-out origin/investor)

Beyond the preview

Go deeper on OBS Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OBS Medical.

Explore the full profile